Envoy Medical (COCH) Preferred Stock Liabilities (2021 - 2026)

Envoy Medical (COCH) has 5 years of Preferred Stock Liabilities data on file, last reported at $391000.0 in Q1 2026.

• For the quarter ending Q1 2026, Preferred Stock Liabilities changed N/A year-over-year to $391000.0; the trailing twelve-month figure through Mar 2026 stood at $391000.0 (changed N/A YoY), and the FY2025 full-year result was $391000.0, changed N/A from the prior year.
• Preferred Stock Liabilities steadied at $391000.0 in Q1 2026, from $391000.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $429.7 million in Q4 2022 to a low of $130000.0 in Q3 2025.
• A 4-year average of $199.6 million and a median of $44.6 million in 2023 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities advanced 1.19% in 2022 and tumbled 89.61% in 2023, its largest moves.
• Tracing COCH's Preferred Stock Liabilities over 4 years: stood at $429.7 million in 2022, then sank by 89.62% to $44.6 million in 2023, then slumped by 99.12% to $391000.0 in 2025, then changed by 0.0% to $391000.0 in 2026.
• Business Quant data shows COCH's Preferred Stock Liabilities at $391000.0 in Q1 2026, $391000.0 in Q4 2025, and $130000.0 in Q3 2025.